¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sclerosing injection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing retroperitonitis
    °æÈ­Èĺ¹¸·¿°, °æÈ­¹è¸·µÚ¿°
  • sclerosing solution
    °æÈ­¾×
  • booster injection
    1. Ãß°¡ÁÖ»ç 2. Ãß°¡Á¢Á¾
  • ciliary injection
    ¼¶¸ðÃæÇ÷
  • collagen injection
    ¾Æ±³ÁúÁÖ»ç, Äݶó°ÕÁÖ»ç
  • conjunctival injection
    °á¸·ÃæÇ÷
  • cavernosal injection
    ÇØ¸éüÁÖ»ç
  • dental injection needle
    Ä¡°ú¿ëÁÖ»ç¹Ù´Ã
  • eliciting injection
    À¯¹ßÁÖ»ç
  • endermic injection
    ÇÇ(ºÎ)³»ÁÖ»ç
  • epidural injection
    °æÁú¸·¹Ù±ùÁÖ»ç, °æ¸·¿ÜÁÖ»ç
  • epifascial injection
    ±Ù¸·¿ÜÁÖ»ç, ±Ù¸·¹Ù±ùÁÖ»ç
  • hypodermic injection
    ÇÇÇÏÁÖ»ç, ÇǺιØÁÖ»ç
  • intravascular injection
    Ç÷°ü³»ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³»ÁÖ»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing liposarcoma
    °æÈ­Áö¹æÀ°Á¾
  • sclerosing mastoiditis
    °æÈ­²ÀÁö¿°
  • sclerosing myelitis
    °æÈ­Ã´¼ö¿°
  • subacute sclerosing panencephalitis
    ¾Æ±Þ¼º°æÈ­¹ü³ú¿°
  • sclerosing retroperitonitis
    °æÈ­µÚ¹è¸·¿°, °æÈ­Èĺ¹¸·¿°
  • sclerosing
    °æÈ­-
  • sclerosing solution
    °æÈ­¾×
  • sclerosing osteogenic sarcoma
    °æÈ­»ÀÀ°Á¾, °æÈ­°ñÀ°Á¾
  • booster injection
    Ãß°¡Á¢Á¾, Ãß°¡ÁÖ»ç
  • cavernosal injection
    ÇØ¸éüÁÖ»ç
  • ciliary injection
    ¼¶¸ðÃæÇ÷
  • collagen injection
    ¾Æ±³ÁúÁÖ»ç
  • conjunctival injection
    °á¸·ÃæÇ÷
  • dental injection needle
    Ä¡°ú¿ëÁÖ»ç¹Ù´Ã
  • eliciting injection
    À¯¹ßÁÖ»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • injection, eliciting
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • injection, provocative
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • pre/post gadolinium injection
    Àü/ÈÄ °¡µ¹¸®´½ ÁÖÀÔ
  • preparatory injection
    ÁغñÁÖ»ç(¡­ñ¼ÞÒ).
  • provocative injection
    À¯¹ßÁÖ»ç(ë¯Û¡ñ¼ÞÒ).
  • rapid injection
    ±Þ¼ÓÁÖÀÔ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing agent
    °æÈ­¾à(Ìãûùå·).
  • sclerosing angioma
    °æÈ­¼º ¸Æ°üÁ¾ (¡­ØæÎ·ðþ)
  • sclerosing basal cell carcinoma
    °æÈ­ ±âÀú¼¼Æ÷¾Ï
  • sclerosing cholangitis
    °æÈ­¼º´ãµµ¿°.
  • sclerosing cholangitis
    °æÈ­¼º ´ãµµ¿°
  • sclerosing epithelial hamartoma
    °æÈ­ Ç¥Çǰú¿ÀÁ¾
  • sclerosing gastritis
    °æÈ­¼º À§¿°(¡­êÖæú).
  • sclerosing gastritis
    °æÈ­¼º À§¿°(¡­êÖæú)
  • sclerosing hemangioma
    °æÈ­ Ç÷°üÁ¾
  • sclerosing hemangioma
    °æÈ­¼º Ç÷°üÁ¾(¡­úìηðþ)
  • sclerosing histoplamosis
    °æÈ­¼º È÷½ºÅäÇö󽺸¶Áõ(¡­)ñø
  • sclerosing inflammation
    °æÈ­¼º ¿°Áõ(¡­æúñø)
  • sclerosing keratitis
    °æÈ­°¢¸·¿° (¡­ÊÇØ¯æú).
  • sclerosing keratitis
    °æÈ­¼º °¢¸·¿° (¡­ÊÇØ¯æú)
  • sclerosing lipogranuloma
    °æÈ­ Áö¹æÀ°¾ÆÁ¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NSHD nodular sclerosing Hodgkin disease
PSC patient services coordination; Porter-Silber chromogen; posterior subcapsular cataract; primary scle...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
SL sarcolemma; sclerosing leukoencephalopathy; secondary leukemia; segment length; sensation level; sen...
SSP Sanarelli-Shwartzman phenomenon; subacute sclerosing panencephalitis; slice sensitivity profile; sub...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SC sclerosing cholangitis
EIS Endoscopic Injection Sclerotherapy
FIA Flow Injection Analysis
FI Flow injection
ICSI IVF)-intracytoplasmic sperm injection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • endermic injection
    Çdz» ÁÖ»ç
  • hypodermic injection
    ÇÇÇÏ ÁÖ»ç
    ÇǺΠ¾Æ·¡·Î ÁÖ»ç ¹Ù´ÃÀ» Âñ·¯ ÁÖ»çÇÏ´Â °Í.
  • inferoalveolar block injection
    ÇÏÄ¡Á¶ Àü´Þ ¸¶Ãë
  • infraorbital injection
    ¾È¿ÍÇÏ ÁÖ»ç
  • injection flask
    ÁÖ»ç ÁÖÀÔÇÔ
    ³³Çü ÀÇÄ¡¸¦ ¸Å¸ôÇÑ ÈÄ¿¡ ÁÖ»ç ÁÖÀÔ¹ýÀ¸·Î Á¦ÀÛÇÒ ¼ö ÀÖµµ·Ï °í¾ÈµÈ ÀÇÄ¡ÇÔ.
  • injection molding method
    »çÃâ ¼ºÇü¹ý
  • interligamentary injection syringe
    Ä¡±Ù¸·³» ÁÖÀÔ¿ë ÁÖ»ç±â
  • intra-arterial injection
    µ¿¸Æ³» ÁÖ»ç
  • intraarticular injection
    °üÀý³» ÁÖ»ç
  • intracutaneous injection
    Çdz» ÁÖ»ç
    Çdz»¿¡ ¾à¹°À» ÁÖÀÔÇÏ´Â ¹æ¹ýÀ¸·Î Áúº´ÀÇ Áø´Ü ¹× ¿¹¹æÀ» À§ÇØ Èí¼ö¸¦ ´À¸®°Ô ÇÏ°í ¾àÈ¿¸¦ °¡´ÉÇÑÇÑ Áö¼Ó½Ã۱⸦ ¹Ù¶ó´Â °æ¿ì ¹× ´Ù¸¥ ÁÖ»ç¹ýÀ¸·Î¼­´Â ºÎÀû´çÇÑ ¾àÁ¦ÀÇ °æ¿ì µî¿¡ ÇàÇØÁø´Ù. ¸¹Àº °æ¿ì ¹ÝÀÀÀÌ ´«À¸·Î º¸Àδٴ Ư¡ÀÌ ÀÖ´Ù.
  • intramuscular injection
    ±Ù³» ÁÖ»ç, ±ÙÀ°³» ÁÖ»ç, ±ÙÀ° ÁÖ»ç
    ¾àÁ¦¸¦ ±ÙÀ°¿¡ ÁÖ»çÇÏ´Â °Í. ÇÇÇÏ Áֻ翡 ºñÇØ¼­ Èí¼ö°¡ ºü¸£°í 2-5mlÀ» Àû¿ëÇÒ ¼ö ÀÖ´Ù. ÀÚ±Ø, ÅëÁõÀÌ °­ÇÑ °ÍÀ̳ª À¯¼ºÀÇ ¾àÁ¦ µî ¶Ç Èí¼ö°¡ ³ª»Û °ÍÀÌ ±ÙÀ° Áֻ翡¼­ Àû¿ëµÈ´Ù.
  • intraosseous, interseptal, intrapulpal injection
    °ñ³», Á߰ݰ£, Ä¡¼ö³» ÁÖ»ç
  • intrapulpal injection
    Ä¡¼ö ³» ÁÖ»ç
  • intravascular injection
    Ç÷°ü³» ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³» ÁÖ»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
sclerosing therapy A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
subacute sclerosing leukoencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
subacute sclerosing panencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
focal sclerosing glomerulopathy Focal, segmental glomerulosclerosis reported in adults and children with normal serum complement, progressing to chronic glomerulonephritis.
(05 Mar 2000)
adrenal cortex injection An obsolete treatment involving the parenteral administration of extract of the adrenal cortex; formerly used in treatment of Addison's disease.
(05 Mar 2000)
bolus injection <procedure> The injection of a drug (or drugs) in a high quantity (called a bolus) at once, the opposite of gradual administration (as in intravenous infusion).
(18 Nov 1997)
regular insulin injection A preparation that may contain 20, 40, 80, 100, or 500 USP insulin units per ml, although the trend is toward standardizing all insulin preparations at 100 units per ml; it is administered subcutaneously, occasionally intravenously, and has a rapid onset of action, has a brief duration (5 to 7 hours), and is compatible for mixing with long-acting insulin preparations; used in the treatment of diabetic acidosis and insulin coma.
Synonym: regular insulin injection.
(05 Mar 2000)
Ringer's injection A sterile solution of sodium chloride, potassium chloride, and calcium chloride, containing in each 100 ml between 820 and 900 mg of sodium chloride, between 25 and 35 mg of potassium chloride, and between 30 and 37 mg of calcium chloride; used intravenously as a fluid and electrolyte replenisher.
(05 Mar 2000)
water for injection Water purified by distillation for the preparation of products for parenteral use.
(05 Mar 2000)
collagen injection Correction of superficial soft tissue deformities, acne scars, or age-related skin changes by injection (implantation) of collagen; bovine collagen preparations are commonly used. Prior intradermal testing is necessary to exclude hypersensitivity.
(05 Mar 2000)
selective injection Injection of contrast medium following selective catheterization of a branch artery or vein for angiography.
(05 Mar 2000)
sensitizing injection An injection that sensitises a person so that subsequent exposure to the antigen (allergen) evokes an allergic response.
(05 Mar 2000)
hypodermic injection The administration of a remedy in liquid form by injection into the subcutaneous tissues.
Synonym: hypodermic.
(05 Mar 2000)
neutral beam injection <radiobiology> This is one of the fundamental plasma heating methods. A particle accelerator is used to create fast ion beams (the particle energies are on the order of 100 keV), the ion beam is then passed through a neutral gas region, where the ions neutralise via charge-exchange reactions with the neutral gas. The neutralised beam is then injected into a magnetically confined plasma. The neutral atoms are unaffected (not confined) by the magnetic field, but ionize as they penetrate into the plasma. The high-energy ions then transfer some of their energy to the plasma particles in repeated collisions, and heat the plasma.
(09 Oct 1997)
subcutaneous injection The delivery of a medication into the subcutaneous tissues via injection (for example insulin).
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á